BIOMAT Database Logo BIOMAT Database Logo

Does IGF-1 play a role in the biology of ovarian cancer? 2018

Dominika Majchrzak-Baczmańska, and Andrzej Malinowski, and Ewa Głowacka, and Miłosz Wilczyński
Instytut Centrum Zdrowia Matki Polki, Łódź, Poland. majchrzak.dominika@gmail.com.

The aim of the study was to investigate serum concentrations of the insulin-like growth factor-1 in women with ovarian cancer and healthy controls, and to compare free IGF-1 levels with selected clinical and pathological param-eters. Correlation analysis was used to measure the following: IGF-1 concentration and Ca125; IGF-1 level and the height of the OC patients. The study included 70 patients with OC and 50 healthy controls. Serum concentrations of free IGF-1 were measured in all subjects. Routine diagnostic tests (CBC and USG and Ca125) were performed. Significantly higher serum concentrations of free IGF-1 were found in the study group as compared to controls. No statistically significant relationships between IGF-1 serum concentrations and tumor differentiation, histological type, and disease stage were detected. No statistically significant correlations between IGF-1 and Ca125 level or between IGF-1 and growth of OC patients were found. Serum IGF-1 participates in the etiopathogenesis of ovarian cancer in menstruating women, while local synthesis of this factor and other components of the autocrine loop of the IGF-1 system play a greater role in their post-menopausal peers.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D005260 Female Females
D006080 Ovarian Follicle An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS. Graafian Follicle,Atretic Follicle,Ovarian Follicles,Atretic Follicles,Follicle, Atretic,Follicle, Graafian,Follicle, Ovarian,Follicles, Atretic,Follicles, Graafian,Follicles, Ovarian,Graafian Follicles
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Dominika Majchrzak-Baczmańska, and Andrzej Malinowski, and Ewa Głowacka, and Miłosz Wilczyński
Does the GH-IGF axis play a role in cancer pathogenesis?
December 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
Dominika Majchrzak-Baczmańska, and Andrzej Malinowski, and Ewa Głowacka, and Miłosz Wilczyński
Does IGF-1 play a role in the etiopathogenesis of non-functioning adrenocortical adenoma?
November 2018, Journal of endocrinological investigation,
Dominika Majchrzak-Baczmańska, and Andrzej Malinowski, and Ewa Głowacka, and Miłosz Wilczyński
Does hCG or hCGβ play a role in cancer cell biology?
November 2010, Molecular and cellular endocrinology,
Dominika Majchrzak-Baczmańska, and Andrzej Malinowski, and Ewa Głowacka, and Miłosz Wilczyński
Does MIS Play a Role in the Treatment of Advanced Ovarian Cancer?
July 2022, Cancers,
Dominika Majchrzak-Baczmańska, and Andrzej Malinowski, and Ewa Głowacka, and Miłosz Wilczyński
The IGF-1 receptor in cancer biology.
December 2003, International journal of cancer,
Dominika Majchrzak-Baczmańska, and Andrzej Malinowski, and Ewa Głowacka, and Miłosz Wilczyński
Does ovarian autoimmunity play a role in the pathophysiology of premature ovarian insufficiency?
January 2010, Journal of mid-life health,
Dominika Majchrzak-Baczmańska, and Andrzej Malinowski, and Ewa Głowacka, and Miłosz Wilczyński
Does prolactin play a role in skin biology and pathology?
September 1991, Medical hypotheses,
Dominika Majchrzak-Baczmańska, and Andrzej Malinowski, and Ewa Głowacka, and Miłosz Wilczyński
Cancer-associated Dermatomyositis: Does the PD-1 Checkpoint Pathway Play a Role?
June 2018, The Journal of rheumatology,
Dominika Majchrzak-Baczmańska, and Andrzej Malinowski, and Ewa Głowacka, and Miłosz Wilczyński
Does autoimmunity play a role in the pathophysiology of premature ovarian ageing?
June 2008, Reproductive biomedicine online,
Dominika Majchrzak-Baczmańska, and Andrzej Malinowski, and Ewa Głowacka, and Miłosz Wilczyński
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer.
April 1999, Biochimie,
Copied contents to your clipboard!